News

NKF's Propofol Injectable Emulsion has been approved by the US FDA and is about to enter the US market!

NKF's subsidiary Kindos's Dalbavancin for Injection gets FDA approval for marketing

NKF sincerely invites global customers to gather at CPHI Europe to explore new opportunities for cooperation together!

NKF attended the 25th anniversary celebration of GMS in Pakistan to deepen strategic cooperation

NKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing

NKF makes its debut at CPHI Southeast Asia

King-Friend will meet you in CPHI Malaysia！

NKF's subsidiary Kindos's Hydralazine Hydrochloride Injection gets FDA